Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor—BCX-1777

Martin, 1981, Biochemistry of diseases of immunodevelopment, Annu. Rev. Biochem., 50, 845, 10.1146/annurev.bi.50.070181.004213 Giblett, 1975, Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity, Lancet, 1, 1010, 10.1016/S0140-6736(75)91950-9 Markert, 1991, Purine nucleoside phosphorylase deficiency, Immunodefic. Rev., 3, 45 Kazmers, 1981, Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T-lymphocytes, Science, 214, 1137, 10.1126/science.6795718 Dong, 1993, PD 141955 and CI-972. 9-deazaguanine analog purine nucleoside phosphorylase inhibitors: II. Effects on nucleoside catabolism in human and rat blood in vitro, Agents Actions, 39, C99, 10.1007/BF01972733 Viegas, 2000, Pharmacokinetics and pharmacodynamics of Peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers, J. Clin. Pharmacol., 40, 410, 10.1177/00912700022008991 Bantia, 2001, Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)—a novel potent and orally active immunosuppressive agent, Int. Immunopharmacol., 1, 1199, 10.1016/S1567-5769(01)00056-X Miles, 1998, One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase, Biochemistry, 37, 8615, 10.1021/bi980658d Kicska, 2001, Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes, Proc. Natl. Acad. Sci., 98, 4593, 10.1073/pnas.071050798 Rizzardi, 2002, Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy, JCI, 109, 681, 10.1172/JCI0214522 Sherman, 1989, Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers, Anal. Biochem., 180, 222, 10.1016/0003-2697(89)90420-X Bantia, 2002, Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777, Int. Immunopharmacol., 2, 913, 10.1016/S1567-5769(02)00034-6 Cohen, 1976, Abnormal purine metabolism and purine overproduction in a patient deficient of purine nucleoside phosphorylase, N. Engl. J. Med., 295, 1449, 10.1056/NEJM197612232952603 Krenitsky, 1976, Deoxycytidine kinase from calf thymus: substrate and inhibitor specificity, J. Biol. Chem., 251, 4055, 10.1016/S0021-9258(17)33354-9 Kazmers, 1981, Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T-lymphocytes, Science, 214, 1137, 10.1126/science.6795718 Eriksson, 1979, Allosteric regulation of calf thymus ribonucleoside diphosphate reductase, Biochemistry, 18, 2946, 10.1021/bi00581a005 Oliver, 1996, dNTP pools imbalance as a signal to initiate apoptosis, Experentia, 52, 995, 10.1007/BF01920108 Hirota, 1989, Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells, Cancer Res., 49, 915 Oliver, 1996, Regulation of the salvage pathway of deoxynucleotide synthesis in apoptosis induced by growth factor deprivation, Biochem. J., 316, 421, 10.1042/bj3160421 Meuth, 1989, The molecular basis of mutation induced by dNTP pool imbalances in mammalian cells, Exp. Cell Res., 181, 305, 10.1016/0014-4827(89)90090-6